Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
Health Technology » Biotechnology
|VRTX||Vertex Pharmaceuticals, Inc.||3.74%||305.53||1.9%||$437.49m|
|GILD||Gilead Sciences, Inc.||5.16%||66.21||1.0%||$435.11m|
|REGN||Regeneron Pharmaceuticals, Inc.||2.32%||643.29||2.6%||$372.05m|
|SNSS||Sunesis Pharmaceuticals, Inc.||5.74%||4.42||0.7%||$308.97m|
|GOVX||GeoVax Labs, Inc.||1.59%||2.55||0.0%||$140.51m|
|BMRN||BioMarin Pharmaceutical, Inc.||1.97%||96.94||4.2%||$104.96m|
|CRSP||CRISPR Therapeutics AG||1.88%||80.14||0.6%||$104.75m|
|PACB||Pacific Biosciences of California, Inc.||-4.89%||8.36||6.2%||$98.27m|
|MRTX||Mirati Therapeutics, Inc.||-0.06%||86.32||1.6%||$96.84m|
INmune Bio, Inc. Is a clinical stage biotechnology company, which engages in developing new immunotherapies that reprograms the immune system to fight cancer and Alzheimerâ€™s disease. Its products include pipeline, INKMUNE-Cancer, INB03-Cancer, XPRO1595-Alzheimer and TRD, and LIVNate. The company was founded by Mark Lowdell in September 2015 and is headquartered in Boca Raton, FL.